Balstilimab
Balstilimab (AGEN2034) is a fully human monoclonal IgG4 antibody against PD-1[1].
Product Specifications
CAS Number
[2148321-77-9]
Product Name Alternative
AGEN2034
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/balstilimab.html
Purity
99.51
Solubility
H2O
Smiles
[Balstilimab]
Molecular Weight
(143.33 kDa)
References & Citations
[1]Drouin E E, et al. AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary human T cell assays and in a non-human primate pharmacodynamic (PD) model. Cancer Research, 2017, 77 (13_Supplement) : 3654-3654.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1147233-01 0.02 mg (E-Coli)
Recombinant Human HERV-V_19q13.41 provirus ancestral Env polyprotein 1 (ERVV-1), partial
Ask
View Details 
MBS1147233-02 0.02 mg (Yeast)
Recombinant Human HERV-V_19q13.41 provirus ancestral Env polyprotein 1 (ERVV-1), partial
Ask
View Details 
MBS1147233-03 0.1 mg (E-Coli)
Recombinant Human HERV-V_19q13.41 provirus ancestral Env polyprotein 1 (ERVV-1), partial
Ask
View Details MBS1147233-04 0.1 mg (Yeast)
Recombinant Human HERV-V_19q13.41 provirus ancestral Env polyprotein 1 (ERVV-1), partial
Ask
View Details MBS1147233-05 0.02 mg (Baculovirus)
Recombinant Human HERV-V_19q13.41 provirus ancestral Env polyprotein 1 (ERVV-1), partial
Ask
View Details